DCTs Background Climedo Health
Climedo Health

 Decentralized Clinical Trials – State of the Industry: Survey Results

+++ Recently featured by Outsourcing-Pharma: Survey: research industry keen on DCT benefits, slow to adopt +++

 

Decentralized clinical trials — Where do we stand?

In the fall of 2021, Climedo Health conducted a survey to assess the state of DCTs adoption in companies, and the associated benefits and potential challenges.

108 respondents from Europe and North America participated in the survey, including numerous manufacturers from medtech and pharma.

The survey addressed the following areas:

  • DCT experience and degree of decentralization, study designs and technologies used
  • Challenges of traditional clinical trials, barriers to DCT adoption
  • Perceived potential of DCTs as well as experienced benefits of DCTs
  • A look at the future of decentralized clinical trials

If you have any questions about the results, please feel free to contact us at: hello@climedo.de

 

About Climedo Health

Climedo Health's mission is to bring the best treatment to every patient by empowering healthcare professionals with intelligent software solutions. Together with Europe’s leading hospitals, we have developed a cloud-based platform for cutting-edge clinical validation and post-market surveillance of medical devices and pharmaceutical products.

By digitally connecting all stakeholders (Medical Device manufacturers, Pharma companies, CROs, hospitals and patients), Climedo allows for increased performance, better cost-efficiencies – and ultimately – accelerated medical innovation. 

Learn more: www.climedo.com.